Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques

被引:88
作者
Nishimura, Y
Brown, CR
Mattapallil, JJ
Igarashi, T
Buckler-White, A
Lafont, BAP
Hirsch, VM
Roederer, M
Martin, MA [1 ]
机构
[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
关键词
acute infection; animal model; CXCR4-tropic SHIV; HIV pathogenesis;
D O I
10.1073/pnas.0503233102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unlike HIV-1 and simian immunodeficiency virus (SIV), which induce a slow, unrelenting loss of immune function spanning several years, highly pathogenic simian-human immunodeficiency viruses (SHIVs) induce a rapid, complete, and irreversible depletion of CD4(+) T lymphocytes in rhesus monkeys within weeks of infection, leading to death from immunodeficiency. We recently reported that, because these SHIVs exclusively use the CXCR4 coreceptor for cell entry, they target naive CD4(+) T cells for depletion in infected monkeys, whereas SIVs, which use CCR5, not CXCR4, cause the selective loss of memory CD4(+) T lymphocytes in vivo. Here we show both by DNA PCR analyses and infectivity assays, using live sorted CD4(+) T lymphocyte subsets, that 30-90% of circulating naive cells were productively infected by day 10 after inoculation. This result implies that direct cell killing, not bystander apoptosis, is responsible for the massive loss of CD4(+) T cells in the X4-tropic SHIV model. Furthermore, we directly demonstrate that > 96% of virus producing cells did not express the Ki-67 proliferation marker on day 10 after inoculation using confocal microscopic analysis of lymph nodes samples. This finding is consistent with the prodigious levels of plasma viremia measured during acute X4-tropic SHIV infections of macaques being generated almost entirely by resting naive CD4(+) T cells.
引用
收藏
页码:8000 / 8005
页数:6
相关论文
共 44 条
  • [1] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [2] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [3] Bjorndal A, 1997, J VIROL, V71, P7478
  • [4] In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline
    Blaak, H
    van't Wout, AB
    Brouwer, M
    Hooibrink, B
    Hovenkamp, E
    Schuitemaker, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) : 1269 - 1274
  • [5] CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    Brenchley, JM
    Schacker, TW
    Ruff, LE
    Price, DA
    Taylor, JH
    Beilman, GJ
    Nguyen, PL
    Khoruts, A
    Larson, M
    Haase, AT
    Douek, DC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) : 749 - 759
  • [6] *COMM CAR US LAB A, 1985, DHSS PUBL, V8523
  • [7] SYNCYTIUM-INDUCING (SI) PHENOTYPE SUPPRESSION AT SEROCONVERSION AFTER INTRAMUSCULAR INOCULATION OF A NON-SYNCYTIUM-INDUCING/SI PHENOTYPICALLY MIXED HUMAN-IMMUNODEFICIENCY-VIRUS POPULATION
    CORNELISSEN, M
    MULDERKAMPINGA, G
    VEENSTRA, J
    ZORGDRAGER, F
    KUIKEN, C
    HARTMAN, S
    DEKKER, J
    VANDERHOEK, L
    SOL, C
    COUTINHO, R
    GOUDSMIT, J
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (03) : 1810 - 1818
  • [8] DESROSIERS RC, 2001, FIELDS VIROLOGY, P2095
  • [9] HIV preferentially infects HIV-specific CD4+ T cells
    Douek, DC
    Brenchley, JM
    Betts, MR
    Ambrozak, DR
    Hill, BJ
    Okamoto, Y
    Casazza, JP
    Kuruppu, J
    Kuntsman, K
    Wolinsky, S
    Grossman, Z
    Dybul, M
    Oxenius, A
    Price, DA
    Connors, M
    Koup, RA
    [J]. NATURE, 2002, 417 (6884) : 95 - 98
  • [10] HIV-1 actively replicates in naive CD4+ T cells residing within human lymphoid tissues
    Eckstein, DA
    Penn, ML
    Korin, YD
    Scripture-Adams, DD
    Zack, JA
    Kreisberg, JF
    Roederer, M
    Sherman, MP
    Chin, PS
    Goldsmith, MA
    [J]. IMMUNITY, 2001, 15 (04) : 671 - 682